Agilon Health (AGL) Stock Price, News & Analysis

Company Overview

Agilon Health, Inc. is a healthcare company that helps primary care physicians transition from traditional fee-for-service medicine to value-based care. The company primarily works with independent physician practices that serve older adults, particularly Medicare Advantage members, with the goal of improving care coordination, patient outcomes and the overall healthcare experience.

Agilon provides a technology and services platform designed to support population health management. Its offerings include data analytics, clinical and administrative workflows, practice management support, care coordination resources and assistance with payer contracting. Through these capabilities, the company helps physicians manage the health needs of their patient populations while taking greater responsibility for quality and cost outcomes.

Founded in 2016, Agilon Health partners with physician organizations in local communities across the United States. Its model is built around long-term relationships with primary care providers, payers and other healthcare participants, with services tailored to the needs of each market. The company is led by President and Chief Executive Officer Steve Sell.

Key Stats

• Today's Range: $82.60 to $85.83
• 50-Day Range: $75.85 to $106.55
• 52-Week Range: $7.48 to $133.04
• Volume: 188,126 shs
• Average Volume: 333,789 shs
• Market Capitalization: $1.42 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $102.25
• Consensus Rating: Hold

Agilon Health Stock Analysis - MarketRank™

Agilon Health scored higher than 37% of companies evaluated by MarketBeat, and ranked 677th out of 888 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.8 / 5
• Analyst Rating: Hold

Consensus Rating

Agilon Health has received a consensus rating of Hold. The company's average rating score is 2.27, and is based on no strong buy ratings, 6 buy ratings, 7 hold ratings, and 2 sell ratings.

Upside Potential

Agilon Health has a consensus price target of $102.25, representing about 20.9% upside from its current price of $84.57.

Amount of Analyst Coverage

Agilon Health has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Agilon Health are expected to grow in the coming year, from ($2.90) to $1.20 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Agilon Health is -5.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Agilon Health is -5.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Agilon Health has a P/B Ratio of 11.07. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

6.42% of the float of Agilon Health has been sold short.

Short Interest Ratio / Days to Cover

Agilon Health has a short interest ratio ("days to cover") of 6.23.

Change versus previous month

Short interest in Agilon Health has recently decreased by 2.77%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Agilon Health does not currently pay a dividend.

Dividend Growth

Agilon Health does not have a long track record of dividend growth.

Dividend Sustainability

Based on EPS estimates, Agilon Health will have a dividend payout ratio of 150.00% in the coming year. This indicates that Agilon Health may not be able to sustain their current dividend.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 3 news articles for Agilon Health this week, compared to 7 articles on an average week.

MarketBeat Follows

3 people have added Agilon Health to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.1 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Agilon Health insiders have not sold or bought any company stock.

Percentage Held by Insiders

2.50% of the stock of Agilon Health is held by insiders.

Percentage Held by Institutions

Agilon Health has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 8/05/2026
• Today: 10/05/2026
• Next Earnings (Estimated): 11/03/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NYSE:AGL
• CIK: 1831097
• Web: agilonhealth.com
• Phone: 562-256-3800
• Fax: N/A
• Employees: 856
• Year Founded: 2016

Price Target and Rating

• Average Price Target for Agilon Health: $102.25
• High Price Target: $146.00
• Low Price Target: $48.00
• Potential Upside/Downside: +20.9%
• Consensus Rating: Hold
• Rating Score (0-4): 2.27
• Research Coverage: 15 Analysts

Profitability

• EPS (Trailing Twelve Months): ($14.27)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$391.35 million
• Net Margins: -3.92%
• Pretax Margin: -4.23%
• Return on Equity: -119.38%
• Return on Assets: -16.85%

Debt

• Debt-to-Equity Ratio: 0.07
• Current Ratio: 1.08
• Quick Ratio: 1.08

Sales & Book Value

• Annual Sales: $5.93 billion
• Price / Sales: 0.24
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $7.64 per share
• Price / Book: 11.07

Miscellaneous

• Outstanding Shares: 16,790,000
• Free Float: 16,371,000
• Market Cap: $1.42 billion
• Optionable: Not Optionable
• Beta: 2.98